Morning, mooers!
This week, $MAYBANK (1155.MY)$ (11/26) and $PBBANK (1295.MY)$ (11/27) are said to report their quarterly earnings. After the recent pullback, investors are focusing on the performance of these two local banking giants. Who will be the winner of earnings week? Make your choice and grab some point rewards!
Rewards
● An equal share of 5,000 points: For mooers who correctly guessed the winner who makes the biggest % gains in...

$GENETEC (0104.MY)$ let's go? or another trap? how you think.

$GENM (4715.MY)$ Is it a good time to buy this stock now?

$MYEG (0138.MY)$ After the performance report for the third quarter was announced yesterday, investors are believed not to be disappointed as both revenue and profit continue to grow.
Here, investors will not comment on the performance because there are already many reports and articles about MYEG's performance that can be referred to.
However, an article about MYEG from The Edge today has caught the attention of investors. This note is made here for future reference.
Attached is a screenshot of this report. The key points have been marked for the convenience of all stock friends. In this report, Ma Bank's investment bank stated:
1. Until the first half of 2025, MyEG will continue to sell 1 million tokens every quarter, and these tokens are expected to be included in the cryptocurrency exchange traded fund (ETF) launched by MaiCapital in Hong Kong.
2. The application of COO (Certificate of Origin) in Ztrade business has doubled in growth, reaching 0.01 million applications per month by the end of the fourth quarter of 2024.
3. The iris authentication scan of World Coin, founded by Chat GPT, the father of Open AI, and Ultraman, has grown to 15,000 applications daily in October and November of this year.
At this point, I believe many stock enthusiasts will be curious about Ultraman and MY...

$METRO (0329.MY)$ Just starting to make a loss upon listing may indeed not be a good sign for some investors, but why not consider it before investing? It's important to note that this stock is not a technology stock, not a financial stock, and definitely not a high-yield stock. It is simply a stock specialized in the medical field. Investing in this stock requires preparation for long-term warfare. Otherwise, it's better not to invest in this stock. Making a loss immediately upon listing is actually a normal phenomenon because the market is still unsure of the accomplishments it can provide us. I also invested in this stock and experienced losses, but it's not necessary to label it as bad just because of this downturn. Perhaps others are even more anxious than us. Not being able to deliver actual results at the time of listing is the hardest blow they can receive.

Recap: S&P 500 Recent Performance: November 1–17, 2024
The $S&P 500 Index (.SPX.US)$ $SPDR S&P 500 ETF (SPY.US)$ has demonstrated strong gains this year, but November has seen mixed momentum: November 1–8: The index surpass past 6,000 (ATH: 6017🥳🥳🥳), supported by solid earnings reports, improved consumer sentiment, and optimism about future Federal reserve rate cuts.  November 11–17: The $S&P 500 Index (.SPX.US)$ $SPDR S&P 500 ETF (SPY.US)$ retreated...

$CEB (5311.MY)$
There is a meeting tomorrow 😬. Will it rise or fall?